Supplemental material
Drug Delivery
Volume 30, 2023 - Issue 1
Research Article
First-in-human study to assess the pharmacokinetics, tolerability, and safety of single-dose oxybutynin hydrochloride administered via a microprocessor-controlled intravaginal ring
, 
, , , , , , & show all
Lisa Paganb Centre for Human Drug Research, Leiden, The Netherlands;c Department of Gynaecology and Obstetrics, Leiden University Medical Centre, Leiden, The Netherlandshttps://orcid.org/0000-0002-2064-7501View further author information
https://orcid.org/0000-0002-2064-7501View further author information, R. Karl Malcolmd School of Pharmacy, Queen’s University Belfast, United KingdomCorrespondence[email protected]
https://orcid.org/0000-0002-1276-7095View further author information
https://orcid.org/0000-0002-1276-7095View further author information, Maarten Wiegerincka LiGalli, The Hague, The Netherlandshttps://orcid.org/0000-0002-8683-5767View further author information
https://orcid.org/0000-0002-8683-5767View further author information, , Bertine Huismanb Centre for Human Drug Research, Leiden, The Netherlands;c Department of Gynaecology and Obstetrics, Leiden University Medical Centre, Leiden, The Netherlandshttps://orcid.org/0000-0002-0807-0658View further author information
https://orcid.org/0000-0002-0807-0658View further author information, Rik Stuurmanb Centre for Human Drug Research, Leiden, The Netherlands;e Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlandshttps://orcid.org/0000-0002-0013-8355View further author information
https://orcid.org/0000-0002-0013-8355View further author information, Michiel van Esdonkb Centre for Human Drug Research, Leiden, The Netherlandshttps://orcid.org/0000-0001-8159-0273View further author information
https://orcid.org/0000-0001-8159-0273View further author information & show all